Rhythm Pharmaceuticals, Inc. (RYTM)
116.69
+9.21
(+8.57%)
USD |
NASDAQ |
Nov 17, 16:00
117.50
+0.81
(+0.69%)
After-Hours: 20:00
Rhythm Pharmaceuticals Price : 116.69 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 113.23 | 115.07 | 107.20 | 107.48 | 964694.0 |
| Nov 13, 2026 | 109.81 | 117.84 | 107.86 | 115.02 | 1.159M |
| Nov 12, 2026 | 112.26 | 112.26 | 108.88 | 109.86 | 1.065M |
| Nov 11, 2026 | 113.76 | 115.20 | 112.04 | 112.16 | 740315.0 |
| Nov 10, 2026 | 113.42 | 115.06 | 112.50 | 113.95 | 616032.0 |
| Nov 09, 2026 | 112.31 | 114.98 | 110.76 | 113.94 | 1.287M |
| Nov 06, 2026 | 107.10 | 113.28 | 104.31 | 112.28 | 4.936M |
| Nov 05, 2026 | 108.76 | 110.66 | 103.06 | 105.02 | 6.396M |
| Nov 04, 2026 | 85.94 | 110.68 | 85.04 | 110.68 | 5.490M |
| Nov 03, 2026 | 84.83 | 89.28 | 81.58 | 86.44 | 7.110M |
| Nov 02, 2026 | 93.13 | 95.35 | 92.40 | 93.44 | 2.004M |
| Oct 30, 2026 | 93.48 | 95.60 | 91.42 | 92.57 | 431656.0 |
| Oct 29, 2026 | 93.00 | 94.16 | 92.52 | 93.07 | 760469.0 |
| Oct 28, 2026 | 91.37 | 92.70 | 91.05 | 91.97 | 533873.0 |
| Oct 27, 2026 | 89.36 | 92.72 | 88.72 | 92.18 | 400170.0 |
| Oct 26, 2026 | 90.07 | 90.81 | 89.00 | 89.47 | 289450.0 |
| Oct 23, 2026 | 90.44 | 90.44 | 88.56 | 89.27 | 536876.0 |
| Oct 22, 2026 | 88.85 | 90.95 | 87.59 | 90.90 | 516394.0 |
| Oct 21, 2026 | 91.02 | 92.18 | 88.12 | 88.62 | 511343.0 |
| Oct 20, 2026 | 88.56 | 91.88 | 88.56 | 90.20 | 877003.0 |
| Oct 19, 2026 | 87.04 | 88.76 | 86.59 | 88.23 | 378787.0 |
| Oct 16, 2026 | 88.20 | 88.62 | 85.91 | 86.17 | 367036.0 |
| Oct 15, 2026 | 88.41 | 90.42 | 87.61 | 87.97 | 644561.0 |
| Oct 14, 2026 | 86.41 | 88.14 | 85.38 | 86.71 | 585836.0 |
| Oct 13, 2026 | 89.63 | 90.50 | 86.35 | 86.61 | 623191.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 156.54 |
| Arrowhead Pharmaceuticals, Inc. | 42.96 |
| BioMarin Pharmaceutical, Inc. | 58.50 |
| Cytokinetics, Inc. | 51.71 |
| Exelixis, Inc. | 68.50 |
Price Related Metrics
| PS Ratio | 28.31 |
| Price to Book Value | 91.95 |
| Earnings Yield | -2.50% |
| Market Cap | 8.088B |